慢性病管理市场规模、份额、成长分析（按疾病类型、管理类型、最终用途、技术和地区）- 2025-2032 年产业预测

2023 年全球慢性病管理市场规模价值 61 亿美元，预计将从 2024 年的 69.8 亿美元成长到 2032 年的 206.3 亿美元，预测期内（2025-2032 年）的复合年增长率为 14.5%。

全球慢性病管理市场正在经历显着成长，这是因为随着生活方式的改变，尤其是在都市区，慢性病的盛行率不断上升。网路普及率的提高提高了人们的健康意识，越来越多的人开始使用线上健康资讯和远端医疗服务，从而扩大了医疗机构的患者群。此外，都市区的空气污染导致呼吸系统疾病增加，进一步增加了对慢性病管理解决方案的需求。老龄化社会进一步增加了需求，因为老年人更容易出现长期健康问题。此外，公司透过健康计画重视员工健康，推动了市场成长，许多公司投资于慢性病管理倡议以支持员工的健康。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析

慢性病管理市场规模（依疾病类型和复合年增长率）（2025-2032）

• 市场概览
• 糖尿病
• 心血管疾病
• 慢性呼吸系统疾病
• 癌症
• 慢性肾臟病

慢性病管理市场规模（按管理类型和复合年增长率）（2025-2032）

• 市场概览
• 生活方式管理
• 药物管理
• 远端医疗服务
• 病患教育
• 监控服务

慢性病管理市场规模（依最终用途和复合年增长率） (2025-2032)

• 市场概览
• 医疗保健提供者
• 病人
• 製药公司
• 保险公司
• 研究组织

慢性病管理市场规模：依技术及复合年增长率（2025-2032）

• 市场概览
• 穿戴式装置
• 行动应用程式
• 云端运算
• 电子健康记录
• 远端医疗

慢性病管理市场规模：按地区和复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Optum, Inc.（USA）
• Medtronic（Ireland）
• Koninklijke Philips NV（Netherlands）
• Abbott Laboratories（USA）
• Siemens Healthineers（Germany）
• Cognizant（USA）
• Infosys Limited（India）
• EXL Service Holdings, Inc.（USA）
• Epic Systems Corporation（USA）
• WellSky（USA）
• ZeOmega（USA）
• Health Catalyst（USA）
• Pegasystems Inc.（USA）
• Cerner Corporation（USA）
• Humana Inc.（USA）
• Teladoc Health, Inc.（USA）
• ChartSpan（USA）
• Signallamp Health（USA）
• Engooden Health（USA）
• Optimize Health（USA）

结论和建议

Global Chronic Disease Management Market size was valued at USD 6.1 billion in 2023 and is poised to grow from USD 6.98 billion in 2024 to USD 20.63 billion by 2032, growing at a CAGR of 14.5% during the forecast period (2025-2032).

The global chronic disease management market is experiencing significant growth driven by the rising prevalence of chronic diseases, particularly in urban areas influenced by changing lifestyle patterns. Increased internet accessibility is enhancing health awareness and expanding Healthcare organizations' patient bases as more individuals utilize online health information and telemedicine services. Additionally, urban air pollution is contributing to a rise in respiratory diseases, further elevating the demand for chronic disease management solutions. The aging population adds another layer of demand, as older individuals are more prone to long-term health issues. Moreover, corporate emphasis on employee health through wellness programs accelerates market growth, with many companies investing in chronic disease management initiatives to support their workforce's well-being.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Chronic Disease Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Chronic Disease Management Market Segments Analysis

Global Chronic Disease Management Market is segmented by Disease Type, Management Type, End Use, Technology and region. Based on Disease Type, the market is segmented into Diabetes, Cardiovascular Diseases, Chronic Respiratory Diseases, Cancer and Chronic Kidney Diseases. Based on Management Type, the market is segmented into Lifestyle Management, Medication Management, Telehealth Services, Patient Education and Monitoring Services. Based on End Use, the market is segmented into Healthcare Providers, Patients, Pharmaceutical Companies, Insurance Companies and Research Organizations. Based on Technology, the market is segmented into Wearable Devices, Mobile Applications, Cloud Computing, Electronic Health Records and Telemedicine. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Chronic Disease Management Market

The Global Chronic Disease Management market is experiencing substantial growth driven by rapid digitalization, which is significantly enhancing health awareness among individuals through real-time health monitoring technologies. Innovations such as smartwatches and fitness bands empower users to continuously track vital signs like blood pressure and heart rate, allowing them to monitor their health conditions effectively. As a result, people are increasingly proactive about their well-being, leading to a rise in patient consultations for fitness and health management. This trend underscores the importance of leveraging technology in chronic disease management, fostering a more informed and health-conscious population.

Restraints in the Global Chronic Disease Management Market

While technological advancements in the healthcare sector are significantly benefiting developed economies, several factors could hinder the growth of the global chronic disease management market. In low-income countries, budget limitations pose challenges to effective treatment for chronic diseases. These financial restrictions prevent the adoption of new technologies within their healthcare systems, ultimately affecting medical outcomes. The disparity in resources and lack of infrastructure in these regions can create a substantial barrier to progress, leading to a slower evolution in chronic disease management practices. Therefore, addressing these constraints is essential for achieving equitable healthcare improvements globally.

Market Trends of the Global Chronic Disease Management Market

The Global Chronic Disease Management market is witnessing a significant shift driven by the rapid development and integration of telemedicine and remote monitoring technologies. This trend has been accelerated by the COVID-19 pandemic, highlighting the necessity of efficient healthcare delivery systems. Telemedicine facilitates convenient consultations for patients, particularly in underserved and rural regions, improving access to essential medical services. Furthermore, remote monitoring allows healthcare providers to track symptoms and health indicators in real-time, promoting early interventions that enhance patient outcomes. As a result, the market is poised for growth, characterized by an increasing demand for innovative solutions that enable effective management of chronic diseases.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Chronic Disease Management Market Size by Disease Type & CAGR (2025-2032)

• Market Overview
• Diabetes
• Cardiovascular Diseases
• Chronic Respiratory Diseases
• Cancer
• Chronic Kidney Diseases

Global Chronic Disease Management Market Size by Management Type & CAGR (2025-2032)

• Market Overview
• Lifestyle Management
• Medication Management
• Telehealth Services
• Patient Education
• Monitoring Services

Global Chronic Disease Management Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Healthcare Providers
• Patients
• Pharmaceutical Companies
• Insurance Companies
• Research Organizations

Global Chronic Disease Management Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Wearable Devices
• Mobile Applications
• Cloud Computing
• Electronic Health Records
• Telemedicine

Global Chronic Disease Management Market Size & CAGR (2025-2032)

• North America (Disease Type, Management Type, End Use, Technology)
  • US
  • Canada
• Europe (Disease Type, Management Type, End Use, Technology)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Disease Type, Management Type, End Use, Technology)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Disease Type, Management Type, End Use, Technology)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Disease Type, Management Type, End Use, Technology)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Optum, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cognizant (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Infosys Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EXL Service Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epic Systems Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WellSky (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZeOmega (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Health Catalyst (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pegasystems Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cerner Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Humana Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teladoc Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ChartSpan (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Signallamp Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Engooden Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Optimize Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations